| SpectraBase Spectrum ID |
8HfnmRSIh04 |
| Name |
N2-(3-Bromobenzyl)-5-methoxytryptamine |
| Classification |
Tryptamine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
358.068076239 u |
| Formula |
C18H19BrN2O |
| InChI |
InChI=1S/C18H19BrN2O/c1-22-16-5-6-18-17(10-16)14(12-21-18)7-8-20-11-13-3-2-4-15(19)9-13/h2-6,9-10,12,20-21H,7-8,11H2,1H3 |
| InChIKey |
LHTQYJJBPUNKOU-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
359.267 g/mol |
| Nominal Mass |
358 u |
| Quality |
998 |
| Retention Index |
2974 |
| SMILES |
C=12C(NC=C2CCNCC=2C=C(C=CC2)Br)=CC=C(C1)OC |
| SPLASH |
splash10-03di-1900000000-b388b1b62af266b4a826 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N-(3-Bromobenzyl)-2-(5-methoxy-1H-indol-3-yl)ethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_020063 |
